BACKGROUND: Transbronchoscopic needle aspiration (TBNA) can offer a unique opportunity to identify surgically unresectable lung cancer and to avoid surgical mediastinal exploration in many patients with mediastinal lymph node extension of the tumor. The aim of this study was to assess the yield of TBNA performed with either histology or cytology needles in mediastinal staging of N2 disease due to non-small cell lung cancer (NSCLC). METHODS: Retrospective chart review was carried out on 194 TBNA procedures performed between January 1997 and September 2000 at a single institution. Inclusion criteria were pathologic evidence of NSCLC; contrast enhancement computed tomography scan of the chest suggesting N2 disease; and negative bronchoscopic examination for possible neoplastic lesions at the site of RESULTS: Overall sensitivity and diagnostic accuracy were 71% and 73%, respectively, with no significant differences between 19-gauge and 22-gauge cytology needles. Procedures performed for right paratracheal and subcarinal lymph node stations had a significantly higher yield than those for the left paratracheal station. CONCLUSIONS: TBNA mediastinal staging, performed during the initial diagnostic evaluation of NSCLC, can spare costs and risks of more invasive procedures in patients with inoperable tumors, in patients who are not candidates for operation because of coexistent significant comorbidities, and in patients with N2 disease.
BACKGROUND: Transbronchoscopic needle aspiration (TBNA) can offer a unique opportunity to identify surgically unresectable lung cancer and to avoid surgical mediastinal exploration in many patients with mediastinal lymph node extension of the tumor. The aim of this study was to assess the yield of TBNA performed with either histology or cytology needles in mediastinal staging of N2 disease due to non-small cell lung cancer (NSCLC). METHODS: Retrospective chart review was carried out on 194 TBNA procedures performed between January 1997 and September 2000 at a single institution. Inclusion criteria were pathologic evidence of NSCLC; contrast enhancement computed tomography scan of the chest suggesting N2 disease; and negative bronchoscopic examination for possible neoplastic lesions at the site of RESULTS: Overall sensitivity and diagnostic accuracy were 71% and 73%, respectively, with no significant differences between 19-gauge and 22-gauge cytology needles. Procedures performed for right paratracheal and subcarinal lymph node stations had a significantly higher yield than those for the left paratracheal station. CONCLUSIONS: TBNA mediastinal staging, performed during the initial diagnostic evaluation of NSCLC, can spare costs and risks of more invasive procedures in patients with inoperable tumors, in patients who are not candidates for operation because of coexistent significant comorbidities, and in patients with N2 disease.
Authors: M Alifano; M C Charpentier; C Perrotin; T J Molina; P Magdeleinat; J Audouin; J-F Regnard; S Camilleri-Broët Journal: Surg Endosc Date: 2005-09-30 Impact factor: 4.584
Authors: Alberto Fernández-Villar; Maribel Botana; Virginia Leiro; Ana González; Cristina Represas; Alberto Ruano-Raviña Journal: BMC Pulm Med Date: 2010-04-28 Impact factor: 3.317
Authors: Michael T Jaklitsch; Lin Gu; Todd Demmy; David H Harpole; Thomas A D'Amico; Robert J McKenna; Mark J Krasna; Leslie J Kohman; Scott J Swanson; Malcolm M DeCamp; Xiaofei Wang; Susan Barry; David J Sugarbaker Journal: J Thorac Cardiovasc Surg Date: 2013-07 Impact factor: 5.209
Authors: Young Rak Choi; Jin Young An; Mi Kyeong Kim; Hye-Suk Han; Ki Hyeong Lee; Si-Wook Kim; Ki Man Lee; Kang Hyeon Choe Journal: Korean J Intern Med Date: 2013-10-29 Impact factor: 2.884
Authors: Erdogan Cetinkaya; Gulsah Gunluoglu; Akif Ozgul; Mehmet Z Gunluoglu; Guler Ozgul; Ekrem C Seyhan; Atayla Gencoglu; Sule Gul Journal: Ann Thorac Med Date: 2011-04 Impact factor: 2.219